CTI regains compliance with all applicable NASDAQ listing standards Cell Therapeutics, Inc.e., NASDAQ Listing Guideline 5550) for continuing listing on The NASDAQ Capital Marketplace and that CTI is usually in compliance with all relevant listing standards. Consequently, the scheduled hearing, which CTI announced in a news release dated May 6 previously, 2011, before the NASDAQ Listing Qualifications Panel offers been cancelled and CTI’s common stock will continue to be listed and exchanged on The NASDAQ CURRENCY MARKETS. Supply Cell Therapeutics, Inc.Both organizations received 20 out-patient sessions of cognitive behavioral therapy over six months, for which the goal was abstinence from alcohol. Seven therapists, all educated both in specific and couples therapy, saw the customers. After the 20 sessions,, each participant received follow-up interviews on the telephone and personally for another full year. For each woman in each of the 18 months of the analysis, researchers calculated the %age of days abstinent and the %age of times of heavy drinking.